IL269133B2 - Eye Drops for Treatment of Sj?gren's Syndrom - Google Patents
Eye Drops for Treatment of Sj?gren's SyndromInfo
- Publication number
- IL269133B2 IL269133B2 IL269133A IL26913319A IL269133B2 IL 269133 B2 IL269133 B2 IL 269133B2 IL 269133 A IL269133 A IL 269133A IL 26913319 A IL26913319 A IL 26913319A IL 269133 B2 IL269133 B2 IL 269133B2
- Authority
- IL
- Israel
- Prior art keywords
- ophthalmic preparation
- aqueous solution
- glycerol
- irritation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762467139P | 2017-03-05 | 2017-03-05 | |
| PCT/IL2018/050184 WO2018163151A1 (en) | 2017-03-05 | 2018-02-19 | Eye drops for treatment of irritation not due to infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL269133A IL269133A (en) | 2019-11-28 |
| IL269133B1 IL269133B1 (en) | 2024-05-01 |
| IL269133B2 true IL269133B2 (en) | 2024-09-01 |
Family
ID=61656085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL269133A IL269133B2 (en) | 2017-03-05 | 2018-02-19 | Eye Drops for Treatment of Sj?gren's Syndrom |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11033513B2 (enExample) |
| EP (2) | EP4385565A3 (enExample) |
| JP (1) | JP7258778B2 (enExample) |
| KR (1) | KR102652879B1 (enExample) |
| CN (1) | CN110891555B (enExample) |
| AU (1) | AU2018230262B2 (enExample) |
| BR (1) | BR112019018367A2 (enExample) |
| CA (1) | CA3055523C (enExample) |
| ES (1) | ES3036888T3 (enExample) |
| IL (1) | IL269133B2 (enExample) |
| MX (1) | MX388961B (enExample) |
| PL (1) | PL3592339T3 (enExample) |
| RU (1) | RU2019130955A (enExample) |
| WO (1) | WO2018163151A1 (enExample) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006123324A1 (en) * | 2005-05-16 | 2006-11-23 | Resdevco Research And Development Co. Ltd., | Topical compositions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| US5895645A (en) * | 1995-01-31 | 1999-04-20 | Bausch & Lomb Incorporated | Opthalmic solution for artificial tears |
| JP3093661B2 (ja) * | 1995-10-12 | 2000-10-03 | 大塚製薬株式会社 | 眼疾患治療剤 |
| AR004214A1 (es) | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| IL120005A (en) * | 1997-01-14 | 2000-08-31 | Ramot University Authority Of | Pharmaceutical compositions for the treatment of the eye |
| US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| DE102005055275A1 (de) | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| IL212725A (en) * | 2011-05-05 | 2016-06-30 | Resdevco Res And Dev Co | Glycerol Preparation for Non-surgical Conjunctivochalysis |
| EP2783689B1 (en) * | 2011-11-24 | 2019-09-25 | Toyo Sugar Refining Co., Ltd. | Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent |
| US9278132B2 (en) | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
-
2018
- 2018-02-19 AU AU2018230262A patent/AU2018230262B2/en active Active
- 2018-02-19 IL IL269133A patent/IL269133B2/en unknown
- 2018-02-19 PL PL18711415.2T patent/PL3592339T3/pl unknown
- 2018-02-19 KR KR1020197029124A patent/KR102652879B1/ko active Active
- 2018-02-19 JP JP2019568840A patent/JP7258778B2/ja active Active
- 2018-02-19 ES ES18711415T patent/ES3036888T3/es active Active
- 2018-02-19 MX MX2019010471A patent/MX388961B/es unknown
- 2018-02-19 CN CN201880029944.8A patent/CN110891555B/zh active Active
- 2018-02-19 WO PCT/IL2018/050184 patent/WO2018163151A1/en not_active Ceased
- 2018-02-19 RU RU2019130955A patent/RU2019130955A/ru unknown
- 2018-02-19 BR BR112019018367A patent/BR112019018367A2/pt not_active Application Discontinuation
- 2018-02-19 EP EP24173992.9A patent/EP4385565A3/en active Pending
- 2018-02-19 CA CA3055523A patent/CA3055523C/en active Active
- 2018-02-19 EP EP18711415.2A patent/EP3592339B1/en active Active
-
2019
- 2019-09-04 US US16/560,084 patent/US11033513B2/en active Active
-
2021
- 2021-03-03 US US17/191,191 patent/US11426361B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006123324A1 (en) * | 2005-05-16 | 2006-11-23 | Resdevco Research And Development Co. Ltd., | Topical compositions |
Non-Patent Citations (5)
| Title |
|---|
| ANONYMOUS:, SJGREN’S SYNDROME, 27 February 2017 (2017-02-27) * |
| GENSHEIMER WILLIAM G., ET AL.:, NOVEL FORMULATION OF GLYCERIN 1% ARTIFICIAL TEARS EXTENDS TEAR FILM BREAK-UP TIME COMPARED WITH SYSTANE LUBRICANT EYE DROPS., 31 December 2012 (2012-12-31) * |
| KISS HUBA J., AND JANOS NEMETH:, ISOTONIC GLYCEROL AND SODIUM HYALURONATE CONTAINING ARTIFICIAL TEAR DECREASES CONJUNCTIVOCHALASIS AFTER ONE AND THREE MONTHS: A SELF-CONTROLLED, UNMASKED STUDY., 14 July 2015 (2015-07-14) * |
| SCRIVANTI M ET AL:, DRY EYE SYNDROME: HYALURONIC ACID EYE DROP (LO2A), 31 December 1996 (1996-12-31) * |
| SOLOMON ABRAHAM, AND SAUL MERIN:, THE EFFECT OF A NEW TEAR SUBSTITUTE CONTAINING GLYCEROL AND HYALURONATE ON KERATOCONJUNCTIVITIS SICCA., 1 December 1998 (1998-12-01) * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018163151A1 (en) | 2018-09-13 |
| CA3055523A1 (en) | 2018-09-13 |
| US20210186892A1 (en) | 2021-06-24 |
| PL3592339T3 (pl) | 2025-09-01 |
| IL269133B1 (en) | 2024-05-01 |
| CN110891555A (zh) | 2020-03-17 |
| US11033513B2 (en) | 2021-06-15 |
| CA3055523C (en) | 2024-10-01 |
| US11426361B2 (en) | 2022-08-30 |
| KR102652879B1 (ko) | 2024-03-29 |
| RU2019130955A3 (enExample) | 2021-06-24 |
| US20190388361A1 (en) | 2019-12-26 |
| JP7258778B2 (ja) | 2023-04-17 |
| AU2018230262A1 (en) | 2019-09-26 |
| AU2018230262B2 (en) | 2024-01-18 |
| EP3592339C0 (en) | 2025-04-30 |
| JP2020509092A (ja) | 2020-03-26 |
| EP3592339B1 (en) | 2025-04-30 |
| KR20190129065A (ko) | 2019-11-19 |
| BR112019018367A2 (pt) | 2020-04-07 |
| CN110891555B (zh) | 2023-12-26 |
| IL269133A (en) | 2019-11-28 |
| EP4385565A2 (en) | 2024-06-19 |
| EP3592339A1 (en) | 2020-01-15 |
| MX2019010471A (es) | 2020-02-12 |
| RU2019130955A (ru) | 2021-04-07 |
| ES3036888T3 (en) | 2025-09-25 |
| EP4385565A3 (en) | 2024-08-21 |
| MX388961B (es) | 2025-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheng et al. | Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment | |
| EP3914244A1 (en) | Pharmaceutical composition for the treatment of ocular neovascularisation | |
| JP2005513106A (ja) | ヘパリンを保有する眼薬剤 | |
| Abbate et al. | Preclinical study of a new matrix to help the ocular surface in dry eye disease | |
| IL269133B1 (en) | Eye Drops for Treatment of Sj?gren's Syndrom | |
| CN110913867B (zh) | 热凝胶化人工泪液 | |
| Camillieri et al. | Effects of hyaluronan on free-radical formation, corneal endothelium damage, and inflammation parameters after phacoemulsification in rabbits | |
| US20090175972A1 (en) | Synergistic herbal ophthalmic formulation for lowering intraocular pressure in case of glaucoma | |
| EP3758688B1 (en) | Nk-1 antagonists for use in the treatment of ocular pain | |
| CN118510520A (zh) | 用于治疗眼部疾病的霉酚酸和/或倍他米松的药物组合物 | |
| EP3150211A1 (en) | Therapeutic agent for keratoconjunctive disorder | |
| US20250360185A1 (en) | Compositions comprising pedf-derived short peptides for the treatment of dry eye diseases | |
| Chen et al. | Exosomal miR-146a derived from human umbilical cord mesenchymal stem cells alleviates inflammation and apoptosis in dry eye disease by targeting SQSTM1 | |
| US8912166B2 (en) | Eye drops for treatment of conjunctivochalasis | |
| EP4454639A1 (en) | Ophthalmic composition comprising carbomer and taurine | |
| US11253565B2 (en) | Nanoparticle ophthalmic composition for the treatment of ocular disorders or diseases | |
| US20230134843A1 (en) | Treatment of stem cell deficiency | |
| Kudyar et al. | Comparison of efficacy of treatment with cyclosporine 0.1% add on therapy with artificial tears (carboxy methyl cellulose 0.5%) & artificial tears alone on dry eye parameters in post cataract surgery patients | |
| Toto et al. | Steroid-Nitroxide Hybrid Compound Protects the Retina | |
| CN120661442A (zh) | 一种滴眼液的组合物及其制备方法和应用 | |
| Kwatra et al. | Routes of Ocular Drug Delivery-Conventional vs. Novel Routes |